Robotic Rehab Devices

Myomo, Inc. manufactures the MyoPro®, an electronically controlled orthotic brace designed to restore functional arm and hand movement in patients with upper-limb paralysis. The device is indicated for individuals with stroke, brachial plexus injury (BPI), cerebral palsy, and other neuromuscular diseases or injuries. The MyoPro uses surface electromyography (sEMG) technology to detect residual muscle signals and trigger controlled electrical stimulation, enabling users to perform functional activities during therapy and in home settings. The company markets to both clinical rehabilitation providers and individual patients. Myomo has achieved Medicare reimbursement under DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) fee schedules, with CPT codes L8701 and L8702 established as of April 2024. The device is custom-fabricated for individual patients and is used primarily in stroke recovery, brachial plexus injury treatment, and veteran rehabilitation programs. The company emphasizes improved activities of daily living (ADL) outcomes and quality-of-life restoration. Myomo supports clinical education through webinars for clinicians, providers, and industry partners. The MyoPro represents a non-invasive, wearable neuroprosthetic approach to upper-limb rehabilitation, combining orthotic support with functional electrical stimulation technology.

CYBERDYNE USA Inc. is a medical robotics and cybernics innovation company developing integrated cyber-physical systems for healthcare and rehabilitation. Founded on the cybernics academic framework—fusing neuroscience, robotics, AI, and engineering—the company manufactures wearable robotic exoskeletons (HAL series) for clinical rehabilitation, mobility assistance, and caregiver support. The HAL Lower Limb Type and Single Joint Type devices enable neuroplastic improvement in gait and joint function through active human-robot interaction. Beyond medical devices, CYBERDYNE produces autonomous hospital robots for cleaning, disinfection, and material transport, alongside communication assistive systems (Cyin, AcousticX) for patients with severe mobility or speech impairments. The company pursues clinical implementation globally through strategic partnerships with universities and healthcare institutions, publishing peer-reviewed research on cybernics treatment outcomes.

HUROTICS Inc. is a Seoul-based medical robotics company specializing in wearable exosuit technology for gait rehabilitation and motor function recovery. The company develops the H-Medi platform, a data-driven wearable robotic system featuring bio-inspired tendon-driven mechanics, variable-elasticity ligament-inspired support, and on-device AI motion analysis. The H-Medi exosuit provides real-time, adaptive gait assistance through lightweight pneumatic and mechanical systems integrated into comfortable apparel. Core competencies include cloud-powered deep learning diagnostics, digital twin analysis for tailored rehabilitation protocols, and clinical validation partnerships with hospitals and research institutions. Products target rehabilitation clinics, hospitals, and research universities seeking evidence-based motorized gait training solutions for stroke recovery, mobility disorders, and athletic performance enhancement.

Neurolutions develops the IpsiHand Upper Extremity Rehabilitation System, an FDA-cleared brain-computer interface (BCI) device for home-based motor recovery therapy in chronic stroke survivors. The non-invasive system comprises an EEG headset that captures motor intention signals from the unimpaired brain hemisphere, a powered wireless handpiece that moves the affected hand, and a tablet interface for guided treatment and progress tracking. Clinical data shows approximately 70% of trial participants improved arm and hand function, with an average 8.1-point improvement on the Fugl-Meyer Assessment within 12 weeks. IpsiHand enables patients to overcome recovery plateaus years or decades post-stroke through autonomous home therapy, with broad insurance coverage including Medicare and VA benefits.

Mirrored Motion Works designs and markets innovative rehabilitation equipment for post-stroke recovery, specifically targeting upper limb rehabilitation. The company's flagship product, the Bimanual Arm Trainer (BAT), employs a revolutionary mirrored motion therapeutic approach combined with video gaming to facilitate motor recovery in patients with asymmetric limb weakness. The evidence-based device helps patients use their unaffected arms to facilitate movement in affected arms, reducing post-stroke synergy patterns and improving active range of motion. FDA Class 1A compliant, the BAT is available for both inpatient and outpatient rehabilitation settings. Mirrored Motion Works provides comprehensive training and support services for patients, therapists, and medical professionals, with the goal of creating a new standard of care in physical rehabilitation and enabling cost-effective home-based therapy protocols.

Torque3 is a neurorehabilitation platform designed specifically for stroke recovery. The system combines deeply immersive virtual reality simulations with advanced robotics to leverage evidence-based approaches to neuroplasticity and task-oriented therapy. The platform features a robotic-assisted simulator that engages patients' entire bodies across sensory, cognitive, and motor domains while providing real-time biometric and motion data collection (20+ million data points per session). Advanced servo motor robotics deliver multimodal feedback including g-forces, haptic ground textures, pedaling resistance, and inertial effects to create convincing immersion. Asymmetrical compensation algorithms allow impaired patients to experience smooth, balanced movement by linking unimpaired-side controls. Designed for clinical rehabilitation centers, the platform aims to improve patient outcomes while reducing therapist injury risk and enabling facilities to significantly increase patient throughput without additional staffing or space expansion.

Motus Nova designs and manufactures FDA Class I cleared robotic exoskeletons for at-home neurological rehabilitation, specializing in stroke recovery and brain injury recovery. The company's flagship products—Motus Hand and Motus Foot—are active-assist robotic devices that deliver clinic-quality therapy in patient homes. These pneumatic-driven systems provide high-dose, gamified rehabilitation using constraint-induced movement therapy and interactive games to enhance motor function, strength, and fine motor control. Available via subscription model (typically $10/hour of use), the devices are covered by most major insurances including Medicare. Motus systems include integrated touchscreen monitoring, real-time progress tracking, clinical support, and personalized therapy protocols. Since 2020, over 3,000 home units have been deployed across all 50 states, with approximately 200 additional devices in clinical settings. Clinical trials at Emory and VA hospitals demonstrated equivalent outcomes between robotic and therapist-delivered therapy, with 82% of users reporting functional improvements within months.

REEV is a medical robotics company specializing in personalized mobility solutions for individuals with neurological gait disorders, including stroke survivors, multiple sclerosis, and paraplegia patients. The company offers an integrated two-product platform: REEV SENSE, an AI-powered wearable gait analysis system that captures real-time kinematic data via dual sensors, and DREEVEN, a motorized knee-ankle-foot orthosis (KAFO) that provides personalized robotic assistance based on patient-specific gait signatures. The system enables certified orthotists and rehabilitation clinics to perform rapid gait calibration, monitor patient progression through mobile analytics, and deliver customized motor control assistance in outpatient and clinical settings. REEV's technology integrates electro-hydraulic actuation with machine learning algorithms to adapt orthotic support dynamically to each patient's walking pattern, improving functional mobility and independence.

Bioness Medical is a California-based medical device manufacturer specializing in neurorehabilitation technologies for patients with stroke, brain injury, spinal cord injury, and other central nervous system disorders. The company develops functional electrical stimulation (FES) systems, robotic body weight support devices, and integrated therapy software platforms for rehabilitation clinics and home use. Their product portfolio includes wearable FES systems for lower-extremity gait correction (L300 Go, L360 Thigh System), upper-extremity hand rehabilitation (H200 Wireless), ceiling-mounted robotic gait systems (Vector), immersive virtual reality therapy platforms (BITS FR), and next-generation exoskeletons (AURA). Bioness also operates Bioness Academy, a comprehensive clinician training platform offering self-paced courses, webinars, and product-specific education in neurorehabilitation best practices.

Assistive Technology Development, Inc. (ATDev) designs and develops innovative robotic assistive technology solutions focused on enhancing independence and quality of life for users with mobility and rehabilitation needs. The company specializes in two primary product lines: Reflex, a telehealth-enabled robotic rehabilitation device for orthopedic knee recovery, and RAMMP (Robotic Assistive Mobility and Manipulation Platform), an intelligent next-generation wheelchair system combining robotic mobility with manipulation capabilities. ATDev's leadership includes experts in exoskeleton research, robotic mobility systems, medical device development, and accessibility advocacy. The company has received federal grant funding (Reflex grants) and collaborates with leading healthcare organizations. Founded by engineers and designers with deep understanding of user needs and assistive technology, ATDev applies cutting-edge robotics and user-centered design principles to create solutions that remove barriers to independence. The organization is positioned in the growing market of robotic rehabilitation and intelligent mobility devices.

Bertec Corporation, founded in 1987 and headquartered in Columbus, Ohio, is a leading manufacturer of research-grade and clinical biomechanical equipment and software for analyzing human movement. With over 30 years of proven expertise, the company serves athletic trainers, physical therapists, researchers, and clinicians worldwide. Bertec's precision-engineered product portfolio includes instrumented treadmills for gait analysis, force plates for measuring ground reaction forces, dynamic posturography systems, and immersive virtual reality platforms for balance assessment and rehabilitation. The company's solutions are designed for both clinical rehabilitation applications and advanced biomechanics research environments. Bertec emphasizes accuracy, reliability, and ease of use across professional healthcare and research settings. The company provides comprehensive customer support, including installation, training, technical troubleshooting, and customized engineering solutions tailored to specific clinical and research requirements.

Robotic Precision Therapy (RPT) operates a clinical service center specializing in robotic-assisted rehabilitation therapy. The company uses the RX2600 Therapeutic Robot, a non-invasive, medication-free device designed to target and relax muscles, correct muscular imbalances, lengthen tight tissues, and improve mobility. The system is marketed for chronic pain relief and functional restoration across a broad range of musculoskeletal conditions including back pain, neck pain, knee pain, shoulder pain, sciatica, migraines, TMJ disorders, carpal tunnel syndrome, scoliosis, plantar fasciitis, disc herniation, spinal stenosis, and sports-related injuries. RPT also treats neurological conditions such as multiple sclerosis and cerebral palsy, as well as performance enhancement for athletes. The clinic operates from a Troy, Michigan location and serves the greater Detroit metropolitan area including Oakland and Macomb counties. Treatment involves initial assessment of muscular imbalance followed by robotic therapy sessions. The company positions itself as an alternative for patients who have exhausted conventional treatment options including medication, exercise, injections, massage, and surgery. While the fetched content does not detail FDA clearance status, manufacturing specifications, or regulatory certifications explicitly, the RX2600 robot appears to be a proprietary therapeutic device. RPT functions primarily as a clinical service provider rather than a medical device manufacturer or distributor.

ExoAtlet is a manufacturer of wearable medical exoskeletons designed for clinical rehabilitation and gait restoration. The company develops powered robotic exoskeletons for patients with spinal cord injuries, multiple sclerosis, cerebral palsy, traumatic brain injury, post-stroke conditions, and those recovering from joint arthroplasty. ExoAtlet's flagship product line includes the ExoAtlet II exoskeleton, engineered to support upright walking and lower-limb weight-bearing therapy. The company operates an ExoRehabilitation program that integrates exoskeleton training with physiotherapy and other rehabilitation modalities to facilitate complete or partial gait restoration and improve patients' social and emotional outcomes. As of the website content, ExoAtlet reports 16 clinical studies, partnerships with 24 clinics, and treatment of over 700 patients. The company is led by CEO and founder Kate Bereziy. ExoAtlet's devices are deployed in clinical settings globally for inpatient and outpatient rehabilitation programs targeting neurological and orthopedic populations requiring assistive mobility restoration.

Tyromotion GmbH is an Austria-based manufacturer of robotic rehabilitation technology founded in 2007, headquartered in Graz with nearly 100 employees and operations in over 65 countries. The company specializes in technology-supported therapeutic devices that combine robotics, sensors, virtual reality, and gamification to enhance motor function and improve quality of life for patients with impairments. Tyromotion develops comprehensive rehabilitation systems for upper and lower extremity recovery, gait training, balance, and functional rehabilitation across all phases of neuro-rehabilitation. Their innovative "Tyrotherapy" approach integrates traditional therapy with advanced technology to support high-intensity, task-specific training. The company also provides Maya, a dedicated rehabilitation therapy documentation and administration software platform that automates clinical workflows.

NextStep Robotics manufactures AMBLE, a wearable robotic device for foot drop gait training and neurorehabilitation. The device targets ankle impairments including foot drop from stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). AMBLE delivers graded robotic assistance with real-time biofeedback, adjusting assistance every step via proprietary algorithms. Key features include rapid donning (under 5 minutes), automatic robotic adjustments, objective progress tracking, and personalized therapy adaptation. Clinical evidence demonstrates 85% of patients discontinued assistive devices or ankle-foot orthoses (AFOs) after 6 weeks of AMBLE treatment. The company has secured $5.5M in NIH grant funding, including Phase 1 and Phase 2 trials. AMBLE is deployed in clinical rehabilitation settings, including University of Maryland Rehabilitation. NextStep positions itself as evidence-driven, with peer-reviewed publications supporting device efficacy. The device addresses a clinical need for affordable robotic rehabilitation solutions accessible to clinics of all sizes, with emphasis on high-intensity dosing, muscle strengthening, and clinician workflow efficiency.

Reha-Stim Medtec GmbH & Co. KG manufactures advanced robotic gait rehabilitation devices and medical treadmills for clinical rehabilitation, outpatient therapy centers, and research applications. The company specializes in innovative end-effector gait trainers, 3D body weight support systems, and high-performance clinical treadmills designed for neurological and orthopedic patients. Primary product lines include the Gait Trainer GT II (an end-effector robotic device for heavily affected patients), The FLOAT (a unique 3D robotic body weight support system enabling real-world simulation and activities of daily living practice), and the Callis Medical Treadmill series (Callis Therapie PRO, Callis Trac 60 PRO, and Callis Ortho PRO) featuring slat belt technology for versatile gait training. The company emphasizes measurable patient outcomes, sensor technologies, and clinician-centered design. Products serve hospitals, rehabilitation facilities, research institutions, and outpatient centers globally, with institutional customers including major university health systems and rehabilitation centers. Reha-Stim positions itself as a leader in robotic rehabilitation technology driven by clinical evidence and patient safety.

Neuro Rehab Recovery Technologies is a clinical solutions developer and distributor specializing in advanced neurorehabilitation equipment and systems. The company operates across North America, with primary headquarters in the USA and distribution presence in Canada, Mexico, Bolivia, Colombia, and Costa Rica. The organization markets itself as clinician-owned and operated, providing a comprehensive portfolio of technologies for neurological injuries and diseases including stroke, cerebral palsy, spinal cord injury, and traumatic brain injury. Product portfolio includes robotic rehabilitation systems (exoskeletons: Keeogo, ExoAtlet EA2), hand rehabilitation devices (SYREBO hand robots, G1 robotic glove, H2 system), functional electrical stimulation systems (G4 FES Foot Drop System), active-passive therapy systems (MOTOmed series for upper and lower extremity), gait training treadmills (AeroRunner anti-gravity system), mirror therapy systems (Syrebo Smart Rehabilitation Mirror), dynamic arm support systems, and VR-based balance assessment and training platforms (UprightVR). The company also distributes the Neuro20 Smart stimulation device and percussive massage equipment. Neuro Rehab Recovery positions itself as a clinical education and training partner rather than a treatment clinic, emphasizing comprehensive training, clinical support, and evidence-based outcomes. The company serves clinics, rehabilitation facilities, hospitals, and individual patients. Major institutional partners include Cleveland Clinic, NewYork-Presbyterian, NYU, CHOP, Northwell Health, and numerous orthotics and prosthetics centers. The organization distributes technologies from multiple global manufacturers and maintains an e-commerce platform for direct consumer sales. No specific FDA clearances or certifications are mentioned on the primary website content provided.

Lifeward is a Massachusetts-based medical device manufacturer specializing in wearable robotic exoskeletons and rehabilitation technology for individuals with neurological disorders including spinal cord injury, stroke, brain injury, and multiple sclerosis. The company's product portfolio includes the ReWalk Personal Exoskeleton for user-initiated walking, the ReStore Exo-Suit for stroke rehabilitation, MYOLYN FES Cycling for functional electrical stimulation, and AlterG Anti-Gravity Systems for gait training and orthopedic recovery. Lifeward's solutions are designed for both clinical rehabilitation settings and home use, with FDA clearance and insurance coverage through major Medicare Advantage carriers. The company serves patients, veterans, and clinicians, offering custom fitting and comprehensive training programs to maximize functional independence and health outcomes in physical rehabilitation and recovery.

NEOFECT Co., Ltd. is a digital rehabilitation technology company specializing in motor neurorehabilitation, hand therapy, and cognitive training systems. The company develops intelligent, sensor-based therapeutic devices that use biofeedback and AI technology to detect and measure even minimal movements of affected limbs, enabling targeted, gamified, evidence-based rehabilitation exercises. Product portfolio includes Smart Board (shoulder and elbow mobility training), Smart Glove (hand, wrist, and finger function improvement), Smart Pegboard (motorically and cognitively focused hand therapy), Smart Kids (pediatric wrist mobility), Cognition (cognitive function training), Smart Balance (postural control and equilibrium training), Innowalk Pro (end-effector-based gait trainer for full-body robotic therapy), Smart Playground (projector-based active movement training with coordination and cognitive elements), Smart VR-Kit (virtual reality–integrated therapy), Tactee (modular eating and daily living aids), and Treax Pads (upper and lower extremity coordination and stability training). Systems deliver audiovisual feedback, measurable performance data, and individualized, progressive exercises suitable for clinic, rehabilitation center, home practice, and mobile/domiciliary settings. Designed for therapeutic compliance and patient motivation through task-focused, playful training. Products are portable, lightweight, and require no internet connectivity for operation. Widely deployed across German-speaking markets in ergotherapy practices, rehabilitation centers, and clinics.

Partners in Medicine LLC is a US-based distributor of FDA-registered assistive and medical devices focused exclusively on upper limb mobility solutions. The company specializes in robotic and powered arm support systems designed to restore independence and functionality for patients with limited or no upper limb mobility. Primary product lines include the Jaco Robotic Arm (a wheelchair-mountable robotic exoskeleton for severe mobility impairment), the O540 Arm Support (a powered wheelchair-integrated system for users with limited arm strength), and the O110 Arm Support (a lightweight mechanical support for daily activities). Partners in Medicine markets to patients, clinicians, occupational therapists, and caregivers across the rehabilitation and assistive technology sectors. The company emphasizes a patient-centric service model, including a 5-year guarantee of free unlimited service and repairs, dedicated family advocacy, and technical support. The company holds FDA registration for its distributed devices and partners with international manufacturers to bring best-in-class foreign-manufactured technologies to the US market. Service capabilities include product training, clinical consultation, loaner device programs, and comprehensive customer support. The organization's stated mission is to establish upper arm mobility as a standard of care in the USA, targeting populations including spinal cord injury, cerebral palsy, ALS, stroke, and other neuromuscular conditions.

medica Medizintechnik GmbH (trading as THERA-Trainer) manufactures robot-assisted and motor-assisted rehabilitation therapy devices for clinical and home use. The company specializes in robotic rehabilitation systems serving acute care, rehabilitation facilities, long-term care, and home therapy markets. THERA-Trainer's product portfolio includes end-effector gait trainers (lyra), cycling trainers (toro), standing/balancing systems, and integrated therapy solutions (balo, tigo) designed for motor recovery and functional improvement across neurological and orthopedic conditions. Products are marketed to healthcare professionals (therapists, physicians, occupational therapists) and patients/caregivers. The company emphasizes user-friendly interfaces, objectified measurement outcomes, proven return on investment for facilities, and suitability for both clinical group therapy and independent home-based training. THERA-Trainer maintains partnerships with major U.S. health systems and rehabilitation networks including Inova, Burke Rehabilitation, Jefferson Health, Baptist Health South Florida, HCA Healthcare, and Encompass Health. The company provides clinical expert support, product demonstrations, technical support, and consultation services. All products are designed with award-winning therapeutic engineering and are marketed as state-of-the-art rehabilitation technology. The organization appears ISO and regulatory-certified for medical device manufacture, though specific certifications are not detailed on the accessible website sections.

Healing Innovations develops the Rise&Walk®, a 3-in-1 robotic neurorehabilitation platform designed for seated, standing, and walking therapy applications. The device serves as a single, operator-friendly station that consolidates multiple rehabilitation modalities, reducing setup time to approximately 5 minutes while enabling 91% of setups and takedowns to be performed independently. The Rise&Walk is deployed across inpatient, outpatient, skilled nursing, LTACH, and community wellness settings, with demonstrated clinical applications in stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease, and cerebral palsy rehabilitation. The platform is actively partnered with major rehabilitation networks including Ernest Health, Shepherd Center, LifePoint Health, TIRR Memorial Hermann, Vibra Healthcare, and Barrett Medical. Clinical outcomes show 80% of patients rate sessions as 8/10 or higher. The company focuses on activity-based technology to improve patient engagement, therapist efficiency, and accessibility across the continuum of care.

Cosmo Robotics Co., Ltd is a South Korean wearable robotics manufacturer specializing in exoskeleton suits and wearable robotic systems for rehabilitation, mobility assistance, and industrial applications. The company develops and manufactures proprietary wearable robot technology domestically and exports globally. Core product lines include the Exoatlet series (EAM, EA2 Pro), pediatric systems (Bambini Kids, Bambini Teens), personal/geriatric assistance (COSuit, EA Personal), and industrial back-support exoskeletons (COSaver Back). The company emphasizes intention recognition technology, natural gait pattern realization, free walking ability expansion, bio-signal-based walking evaluation, and integrated data collection and analysis capabilities. Products address rehabilitation needs across age groups from infants through elderly populations, as well as occupational ergonomics and daily living support. Manufacturing is Korea-based with international distribution networks. The company maintains patents on core exoskeleton technologies and certifications relevant to medical device and wearable robot classifications. Cosmo Robotics positions itself as a leader in the global wearable robotics market with applications spanning clinical rehabilitation, home care, and industrial workplace safety.

Human Motion Technologies LLC (Humotech) is a Pittsburgh-based developer of wearable robotics platforms and emulation systems for research and development in prosthetics, orthotics, exoskeletons, and mobility enhancement technologies. The company provides integrated hardware, software, and technical support enabling researchers and clinics to rapidly design, test, and evaluate wearable assistance devices without costly physical prototyping. Humotech's Caplex® platform serves as a core tool for biomechanics research, clinical decision-making, and technology development across academic institutions, military medical centers, healthcare providers, and commercial partners. The company has deployed 44+ systems globally and holds 5+ patents. Core offerings include multi-degree-of-freedom actuator units, ankle exoskeletons, prosthetic foot emulators, and custom end-effectors configured for specific research applications. Humotech supports gait analysis, metabolic cost optimization, exoskeleton control development, prosthesis mechanics evaluation, and clinical-grade prosthetic foot selection. The company collaborates extensively with elite research teams at Carnegie Mellon, Stanford, Georgia Tech, Vanderbilt, University of Michigan, Walter Reed National Military Medical Center, VA medical centers, and international institutions. Caplex technology enables emulation paradigm workflows—develop, test, and iterate on device concepts with human users prior to engineering-intensive prototyping. The company emphasizes domain expertise, collaborative partnerships, and responsive technical support.

Enable Me is a Tampa, FL-based medical equipment distributor and solutions provider specializing in rehabilitation therapy devices, patient mobility equipment, and ergonomic medical furniture. The company is the primary distributor for MOTOmed (RECK) motorized movement therapy devices—passive and active-assist cycle ergometers designed for patients with limited mobility, neurological conditions, and post-surgical recovery. MOTOmed devices are deployed across acute care hospitals, long-term care facilities, home care, dialysis centers, and veterans' services, with clinical evidence showing average ICU length-of-stay reductions of 2.7 days and enhanced outcomes in pulmonary function, bowel/bladder activity, and mobility. Enable Me also distributes Hasomed functional electronic stimulation (FES) systems for enhanced therapeutic outcomes and Stim2Go portable stimulation devices. The company manufactures and distributes the Independence Chair 700 Series—a height-adjustable, mobility-focused seating solution for users requiring independence and safety in home and workplace settings. Additionally, Enable Me represents VELA Medical ergonomic patient chairs designed for diagnostic imaging, ophthalmology, and mammography workflows; these FDA-registered devices reduce staff injury risk and enhance diagnostic positioning. The company targets hospital systems, skilled nursing facilities, rehabilitation centers, home health agencies, VA and DoD facilities, and individual consumers seeking aging-in-place solutions. All product lines emphasize safety, data capture for CMS compliance, and measurable clinical outcomes. Enable Me functions as both an equipment manufacturer and authorized distributor with direct sales and customer support.

Cheelcare is a Canadian medical device manufacturer based in Richmond Hill, Ontario, specializing in innovative assistive mobility devices and robotic platforms for disabled users. The company engineers power wheelchairs and mobility accessories from R&D through commercialization, featuring patented technologies including self-levelling, omni-directional tilting, and robotic base systems. Cheelcare's product portfolio includes Companion (a power assist attachment for manual wheelchairs), Curio (a cutting-edge power wheelchair with robotic base and unprecedented range of motion), and AWARE (a rear-view camera system for power wheelchairs). The company is committed to advancing user independence and quality of life through advanced engineering and accessible design. All products are designed and built in Canada.

Kinova is a Canadian robotics manufacturer based in Boisbriand, Quebec, specializing in advanced robotic arm systems for medical, assistive, research, and industrial applications. The company designs and manufactures ultra-lightweight manipulators with up to 7 degrees of freedom, featuring advanced sensors and vision-based capabilities. Primary product lines include the Jaco® Assistive Robotic Arm for mobility-challenged individuals, Gen3 and Gen3 Lite arms for dynamic manipulation tasks, Link 6 collaborative robotic arm, and Gen2 legacy systems. Kinova provides end-to-end solutions encompassing design, engineering, certification, system integration, and ongoing technical support. The company serves healthcare institutions, research centers, aerospace, nuclear, and academic sectors, with partnerships spanning over 500 universities and 45 countries globally. Applications include telesurgery systems, total hip arthroplasty automation, remote diagnostic ultrasound, hazardous environment operations, and laboratory automation.

Aretech, LLC is a leader in advanced robotic body-weight support systems for rehabilitation and physical therapy. Founded in 2009 and based in Sterling, Virginia, the company specializes in dynamic body-weight support technologies that create reduced-gravity environments to enable intensive therapy sessions earlier in patient recovery. Aretech's systems compensate for weakness and poor coordination, allowing patients to regain confidence and push therapeutic limits without fear of falling. The company offers four primary product lines: the ZeroG 3D for three-dimensional gait, balance, and activities of daily living training with unrestricted movement; the ZeroG 2D for overground gait, balance, and perturbation activities; the Ovation interactive treadmill system for bariatric patients up to 700 pounds; and the Luminaire BWS treadmill system for smaller therapy spaces. All products support dynamic weight offloading from 10–300 pounds depending on model, feature customizable fall safety settings, and are manufactured in the United States to ISO 13485 standards. Aretech's technology was originally developed by founder Dr. Joe Hidler to assist injured veterans, with initial support from U.S. Military grants.

BTL Industries is a global manufacturer of clinically proven medical and aesthetic equipment, operating since 1993 with headquarters in Prague and locations across 90+ countries. The company specializes in non-invasive therapeutic solutions for aesthetic medicine, rehabilitation and orthopaedics, cardiology and pulmonology, and advanced robotic medical systems. BTL's product portfolio encompasses body shaping and skin tightening devices, electrotherapy and ultrasound therapy systems, high-intensity laser therapy, cryotherapy, spinal decompression, cardiac monitoring and stress testing equipment, spirometry systems, and robotic rehabilitation solutions (R-GAIT, R-TOUCH, R-LEAD brands). The company serves diverse healthcare settings including small medical offices, multidisciplinary medical centers, hospitals, aesthetic clinics, and wellness centers. With approximately 3,700–4,000 employees including 500 engineers, BTL emphasizes clinical validation, technical reliability, comprehensive training programs, and after-sales support as core differentiators in the global medical device market.

MEBSTER Inc. is a Czech medical device manufacturer specializing in cost-effective assistive exoskeletons for individuals with spinal cord injuries and mobility disorders. The company develops the UNILEXA product line—comprising UNILEXA Prime (for clinical and professional rehabilitation settings) and UNILEXA Home (for independent home and community use)—which enable verticalization, gait training, and ambulatory practice. These gravity-driven, lightweight exoskeletons are designed for self-donning and can be used independently or with clinical supervision. MEBSTER also provides the MEBSTER mobile app for progress tracking and motivation. The devices address secondary health complications arising from prolonged immobility, particularly in spinal cord injury patients, while empowering users to maintain physical activity and improve quality of life across both healthcare facilities and home environments.

PARO is an FDA-cleared Class II medical device therapeutic robot developed by AIST (Japan) since 2003, with US clearance since 2009. The interactive robotic seal administers evidence-based animal therapy benefits in clinical and long-term care settings where live animals present logistical or infection-control challenges. PARO features five sensor types (tactile, light, audition, temperature, posture) enabling real-time environmental perception and behavioral learning. The device responds to touch, voice recognition, and caregiver interaction by moving its head and legs, vocalizing, and adapting behavior based on positive/negative reinforcement. Clinical applications address dementia, Alzheimer's disease, PTSD, anxiety, depression, agitation, wandering, self-isolation, sundowning, insomnia, and Long COVID-related isolation. PARO has been certified by Guinness World Records as the "World's Most Therapeutic Robot" and is supported by peer-reviewed research demonstrating stress reduction for both patients and caregivers, improved socialization, enhanced motivation, and psychological relaxation benefits.

Rehabtek LLC, founded in 2000 and headquartered in Chicago, Illinois, specializes in the research and development of advanced rehabilitation technologies for patients with neurological disorders and orthopedic injuries. The company develops medical devices leveraging cutting-edge robotics, signal processing, and biomedical engineering to support physical medicine and rehabilitation clinical practice. Rehabtek maintains close collaboration with the Rehabilitation Institute of Chicago, the nation's #1-ranked rehabilitation hospital. The company's core offering is intelligent robotic rehabilitation systems that combine passive stretching with assistive and resistive active movement training to restore joint range-of-motion, improve muscle strength and control, and facilitate functional recovery. Products are designed for direct clinical application in rehabilitation settings and are grounded in decades of research from leading medical institutions.

Ekso Bionics is a publicly traded leader in wearable exoskeleton technology, founded in 2005 by UC Berkeley experts and headquartered in San Rafael, California. The company develops FDA-cleared robotic exoskeletons for clinical and home rehabilitation, targeting patients with spinal cord injury, stroke, brain injury, and multiple sclerosis. Its healthcare portfolio includes the EksoNR (inpatient rehabilitation), Ekso Indego Therapy (outpatient therapy), and Ekso Indego Personal (home/community use). All products feature Variable Assist technology that adapts power delivery to enhance mobility and functional independence. With 500+ rehabilitation centers worldwide and Medicare coverage eligibility, Ekso Bionics serves hospitals, outpatient facilities, and individuals seeking mobility restoration and neurological recovery support.

HoustonBionics is a medical device company specializing in at-home upper extremity rehabilitation for stroke and traumatic brain injury (TBI) survivors. The company's flagship product, ExoRehab X, is a clinical-grade robotic rehabilitation platform designed to support high-repetition, goal-directed practice of distal upper extremity movements—including wrist flexion/extension, radial/ulnar deviation, and forearm pronation/supination. The system provides interactive, gamified therapy with adaptive assistance or resistance based on patient effort, enabling users to complete 1,000+ repetitions per day. ExoRehab X integrates progress tracking via built-in sensors and is designed for use in clinical settings and at home, complementing rather than replacing clinician-guided care. FDA-registered as a Class I medical device, the platform leverages neuroplasticity principles and research from Rice University and Texas Medical Center partnerships. HoustonBionics partners with health systems and rehabilitation clinics to integrate ExoRehab X into post-discharge care protocols, targeting improved patient engagement, compliance, and functional recovery outcomes.

Plasticity Neurorehabilitation designs and manufactures neurorehabilitation devices focused on neuroplasticity and neuromodulation therapy. The company's primary product, Polyform-1h, is a hand rehabilitation device specifically engineered for neuromuscular re-education and network retraining following neurological injury or other conditions that compromise hand function. The device targets enhancement of functional performance and motor recovery through intelligently designed recovery tools. Founded by Luke K Barr, MD, the company positions itself within a paradigm-shifting approach to rehabilitation challenges. Products are sold direct-to-consumer via their e-commerce platform. The company serves individuals recovering from neurological injuries, disabled veterans, and others seeking improved hand function and neurological recovery.

NeuroTechR3 Inc. develops R3THA, an advanced neurorehabilitation platform designed for individuals recovering from stroke, cerebral palsy, and other neurological conditions. The system combines adaptive, machine learning-driven exergames with real-time biofeedback to enhance hand and arm function recovery. R3THA gamifies rehabilitation therapy, enabling patients to engage in interactive experiences both in clinical and home settings. The platform features remote progress tracking and therapist oversight capabilities to optimize patient adherence and motivation. Clinical evidence demonstrates 20% improvement in Box and Block Test (BBT), 13.6% improvement in Fugl-Meyer Assessment (FMA-UE), and 15.2% improvement in Action Research Arm Test (ARAT) over three months in individuals 6 months to 17 years post-stroke. The company is funded by the National Science Foundation (NSF), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Administration for Community Living (ACL), and New Jersey Economic Development Authority (NJEDA), indicating strong federal and state research support.

MicroTransponder Inc., operating under the brand Vivistim, manufactures FDA-approved breakthrough vagus nerve stimulation (VNS) therapy systems for post-stroke upper limb recovery. The Vivistim system is a wearable neuromodulation device designed to be paired with occupational and physical therapy to enhance neuroplasticity and improve hand and arm function in chronic ischemic stroke survivors. The device delivers targeted vagal stimulation during rehabilitation exercises and daily activities, clinically demonstrated to provide 2–3 times greater improvement in upper limb function compared to intensive therapy alone. FDA-cleared as a breakthrough device for safety and efficacy, the system targets a significant market of stroke survivors with persistent upper limb impairment. The company operates a patient qualification and enrollment model, working with rehabilitation specialists and therapy centers. Clinical evidence supports high user satisfaction (98%) and lasting functional improvements with sustained reduction in impairment. The company partners with leading stroke advocacy and occupational therapy organizations, indicating strong clinical and professional credibility in the neurorehabilitation space.